Ten things to know about oomycete effectors

Sebastian Schornack; Edgar Huitema; Liliana M. Cano; Tolga O. Bozkurt; Ricardo Oliva; Mireille Van Damme; Simon Schwizer; Sylvain Raffaele; Angela Chaparro-Garcia; Rhys Farrer; Maria Eugenia Segretin; Jorunn Bos; Brian J. Haas; Michael C. Zody; Chad Nusbaum; Joe Win; Marco Thines; Sophien Kamoun

doi:10.1111/j.1364-3703.2009.00593.x

Ten things to know about oomycete effectors

Sebastian Schornack
, Edgar Huitema
, Liliana M. Cano
, Tolga O. Bozkurt
, Ricardo Oliva
, Mireille Van Damme
, Simon Schwizer
, Sylvain Raffaele
, Angela Chaparro-Garcia
, Rhys Farrer
, Maria Eugenia Segretin
, Jorunn Bos
, Brian J. Haas
, Michael C. Zody
, Chad Nusbaum
, Joe Win
, Marco Thines
, Sophien Kamoun (Corresponding Author)

Medical Sciences

Research output: Contribution to journal › Article › peer-review

148 Citations (Scopus)

Abstract

Long considered intractable organisms by fungal genetic research standards, the oomycetes have recently moved to the centre stage of research on plant?microbe interactions. Recent work on oomycete effector evolution, trafficking and function has led to major conceptual advances in the science of plant pathology. In this review, we provide a historical perspective on oomycete genetic research and summarize the state of the art in effector biology of plant pathogenic oomycetes by describing what we consider to be the 10 most important concepts about oomycete effectors.

Original language	English
Pages (from-to)	795-803
Number of pages	9
Journal	Molecular Plant Pathology
Volume	10
Issue number	6
Early online date	9 Oct 2009
DOIs	https://doi.org/10.1111/j.1364-3703.2009.00593.x
Publication status	Published - 1 Nov 2009

Bibliographical note

We thank Mark Gijzen for suggestions and for providing back-ground information. Our laboratory is funded by the Gatsby Charitable Foundation, the Biotechnology and Biological Sciences Research Council (BBSRC) and BASF Plant Sciences. SS is supported by a Deutsche Forschungsgemeinschaft (DFG) fellow-ship, TOB is supported by a Marie Curie Intra-European fellow-ship, and MT is supported by a fellowship from the Max Planck Society, the Elite Program for Postdocs of the Landesstiftung Baden-Württemberg, and the German Science foundation (DFG).

Access to Document

10.1111/j.1364-3703.2009.00593.xLicence: Unspecified

Cite this

Schornack, S., Huitema, E., Cano, L. M., Bozkurt, T. O., Oliva, R., Van Damme, M., Schwizer, S., Raffaele, S., Chaparro-Garcia, A., Farrer, R., Segretin, M. E., Bos, J., Haas, B. J., Zody, M. C., Nusbaum, C., Win, J., Thines, M., & Kamoun, S. (2009). Ten things to know about oomycete effectors. Molecular Plant Pathology, 10(6), 795-803. https://doi.org/10.1111/j.1364-3703.2009.00593.x

Schornack, S, Huitema, E, Cano, LM, Bozkurt, TO, Oliva, R, Van Damme, M, Schwizer, S, Raffaele, S, Chaparro-Garcia, A, Farrer, R, Segretin, ME, Bos, J, Haas, BJ, Zody, MC, Nusbaum, C, Win, J, Thines, M & Kamoun, S 2009, 'Ten things to know about oomycete effectors', Molecular Plant Pathology, vol. 10, no. 6, pp. 795-803. https://doi.org/10.1111/j.1364-3703.2009.00593.x

@article{bafaeaa91fd14dc1b60c135fa05ac13a,

title = "Ten things to know about oomycete effectors",

abstract = "Long considered intractable organisms by fungal genetic research standards, the oomycetes have recently moved to the centre stage of research on plant?microbe interactions. Recent work on oomycete effector evolution, trafficking and function has led to major conceptual advances in the science of plant pathology. In this review, we provide a historical perspective on oomycete genetic research and summarize the state of the art in effector biology of plant pathogenic oomycetes by describing what we consider to be the 10 most important concepts about oomycete effectors.",

author = "Sebastian Schornack and Edgar Huitema and Cano, \{Liliana M.\} and Bozkurt, \{Tolga O.\} and Ricardo Oliva and \{Van Damme\}, Mireille and Simon Schwizer and Sylvain Raffaele and Angela Chaparro-Garcia and Rhys Farrer and Segretin, \{Maria Eugenia\} and Jorunn Bos and Haas, \{Brian J.\} and Zody, \{Michael C.\} and Chad Nusbaum and Joe Win and Marco Thines and Sophien Kamoun",

note = "We thank Mark Gijzen for suggestions and for providing back-ground information. Our laboratory is funded by the Gatsby Charitable Foundation, the Biotechnology and Biological Sciences Research Council (BBSRC) and BASF Plant Sciences. SS is supported by a Deutsche Forschungsgemeinschaft (DFG) fellow-ship, TOB is supported by a Marie Curie Intra-European fellow-ship, and MT is supported by a fellowship from the Max Planck Society, the Elite Program for Postdocs of the Landesstiftung Baden-W{\"u}rttemberg, and the German Science foundation (DFG).",

year = "2009",

month = nov,

day = "1",

doi = "10.1111/j.1364-3703.2009.00593.x",

language = "English",

volume = "10",

pages = "795--803",

journal = "Molecular Plant Pathology",

issn = "1464-6722",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Ten things to know about oomycete effectors

AU - Schornack, Sebastian

AU - Huitema, Edgar

AU - Cano, Liliana M.

AU - Bozkurt, Tolga O.

AU - Oliva, Ricardo

AU - Van Damme, Mireille

AU - Schwizer, Simon

AU - Raffaele, Sylvain

AU - Chaparro-Garcia, Angela

AU - Farrer, Rhys

AU - Segretin, Maria Eugenia

AU - Bos, Jorunn

AU - Haas, Brian J.

AU - Zody, Michael C.

AU - Nusbaum, Chad

AU - Win, Joe

AU - Thines, Marco

AU - Kamoun, Sophien

N1 - We thank Mark Gijzen for suggestions and for providing back-ground information. Our laboratory is funded by the Gatsby Charitable Foundation, the Biotechnology and Biological Sciences Research Council (BBSRC) and BASF Plant Sciences. SS is supported by a Deutsche Forschungsgemeinschaft (DFG) fellow-ship, TOB is supported by a Marie Curie Intra-European fellow-ship, and MT is supported by a fellowship from the Max Planck Society, the Elite Program for Postdocs of the Landesstiftung Baden-Württemberg, and the German Science foundation (DFG).

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Long considered intractable organisms by fungal genetic research standards, the oomycetes have recently moved to the centre stage of research on plant?microbe interactions. Recent work on oomycete effector evolution, trafficking and function has led to major conceptual advances in the science of plant pathology. In this review, we provide a historical perspective on oomycete genetic research and summarize the state of the art in effector biology of plant pathogenic oomycetes by describing what we consider to be the 10 most important concepts about oomycete effectors.

AB - Long considered intractable organisms by fungal genetic research standards, the oomycetes have recently moved to the centre stage of research on plant?microbe interactions. Recent work on oomycete effector evolution, trafficking and function has led to major conceptual advances in the science of plant pathology. In this review, we provide a historical perspective on oomycete genetic research and summarize the state of the art in effector biology of plant pathogenic oomycetes by describing what we consider to be the 10 most important concepts about oomycete effectors.

U2 - 10.1111/j.1364-3703.2009.00593.x

DO - 10.1111/j.1364-3703.2009.00593.x

M3 - Article

SN - 1464-6722

VL - 10

SP - 795

EP - 803

JO - Molecular Plant Pathology

JF - Molecular Plant Pathology

IS - 6

ER -

Ten things to know about oomycete effectors

Abstract

Bibliographical note

Access to Document

Fingerprint

Cite this